Get started

Stockpicks

$TSLA: Shorts get Sunk: Bullish Long: $1480 Entry Prior to CallTesla right now has some interesting core pivot points even looking at the recent bull run wedge. Elon Musk seems to be extra confident prior to the earnings call and even if it has a small loss per share, it would still likely continue in its overall bullishness. Do we expect him to meet production quotas? So far, the guy haven't been doing a bad job. Looking at the autofib retracement, you see some key point indications as well as the dynamic points showing a past neutral level for some continued support. Even w/ a short squeeze, you can expect lots of resistance to be broken down. That being said, invest at your own risk. As always, everything I say is on an opinion based basis. Do your own due diligence.
NASDAQ:TSLALong
by gamer456148
3
I Expect $SPCB to retrace past June 24 PivotRight now, looking at the charting patterns and the current pivot correlations for SPCB, I think it should retrace past the June 24th pivot and the resistance curve may be broken soon. My sentiment is positive, and I am overall bullish long thinking this might be a good entry for some of you. That being said, everything I say is on an opinion based basis. Invest at your own risk and do your own due diligence. Please don't take this as serious advice warranting actionable financial events.
NASDAQ:SPCBLong
by gamer456148
ACAD ACADIA PHARMACEUTICALS INC 5X GAINS COMING SOON (HODL)many products releasing soon Sector: Health Technology Industry: Biotechnology Employees: 503 ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA. Valuation Market Capitalization 8.373B Enterprise Value (MRQ) 5.922B Enterprise Value/EBITDA (TTM) — Total Shares Outstanding (MRQ) 155.861M Number of Employees 503 Number of Shareholders 26 Price to Earnings Ratio (TTM) — Price to Revenue Ratio (TTM) 22.1988 Price to Book (FY) 11.6201 Price to Sales (FY) 22.7131 Balance Sheet Quick Ratio (MRQ) 7.1997 Current Ratio (MRQ) 7.2630 Debt to Equity Ratio (MRQ) 0.0141 Net Debt (MRQ) -642.407M Total Debt (MRQ) 8.999M Total Assets (MRQ) 747.45M Operating Metrics Return on Assets (TTM) -0.3812 Return on Equity (TTM) -0.4504 Return on Invested Capital (TTM) -0.4450 Revenue per Employee (TTM) 674107.3559 Price History Average Volume (10 day) 1.571M 1-Year Beta 0.7491 52 Week High 58.7200 52 Week Low 21.5600 Dividends Dividends Paid (FY) 0 Dividends Yield (FY) 0 Dividends per Share (FY) 0 Margins Net Margin (TTM) -0.6499 Gross Margin (TTM) 0.9621 Operating Margin (TTM) -0.6784 Pretax Margin (TTM) -0.6485 Income Statement Basic EPS (FY) -1.5982 Basic EPS (TTM) -1.5783 EPS Diluted (FY) -1.5982 Net Income (FY) -235.259M EBITDA (TTM) -245.781M Gross Profit (MRQ) 86.899M Gross Profit (FY) 327.732M Last Year Revenue (FY) 339.076M Total Revenue (FY) 339.076M Free Cash Flow (TTM) -135.258M
NASDAQ:ACADLong
by MavRich_Trading
4 Penny Stocks I'm Bullish On: MARK, BBI, ADOM, and SLRXThese are currently 4 penny stocks that I'm bullish on for a potential reentry: $MARK been beaten up alot, and I think the resistance might pop soon for a gap fill. BBI has been mostly bearish and should retrace soon for the next positive wedge. ADOM is a long hold. SLRX is one of those stocks that may be due for even another breakout. As always, please pursue at your own risk. Everything I say is on an opinion based basis. Do your own due diligence.
NASDAQ:SLRXLong
by gamer456148
1
TSLA Beat $1750 Today: Next Long Target is $2100Right now Elon Musk seems to be on a roll with Tesla and the bullish bull run continues. Support levels just seem to be at an all time high. The next price point that I'm hoping for is a target of $2100, likely by the end of November but at this rate it can be at the end of October or September. Nothing surprises me anymore. That being said, this is on an opinion based basis. Pursue at your own risk and do your own due diligence. (As always)
NASDAQ:TSLALong
by gamer456148
CLDR: Ready for even another higher growth wedge?CLDR is in the packaged software sector and focusing on data engineering and analytical solutions. Currently, when looking at what they have, you easily see sector and demand growth. Also, the sentiment is bullish likely pushing this to another much larger positive wedge. I think this may be a decent bet for a long hold. The way they have grown over the years in the heart of Silicon Valley also makes me quite hopeful. As always, this is on an opinion based basis. Invest at your own risk and pursue your own due diligence.
CLong
by gamer456148
ABIO: Currently looking for a Long EntryFirst off, please don't take anything I say as financial advice and as always everything is on an opinion based basis. Pursue your own due diligence. That being said, ABIO seems to have a decent setup for potentially another bull run quite soon. The resistance curve is about to pop and it looks like this is a close watch as with other stocks I been watching. In my opinion the risk isn't too high given the mostly neutral pattern after the bearish action that happened kicking off June. At that point, the risk got mostly reduced and this price for an entry isn't too bad. It still though is risky.
ALong
by gamer456148